Home > Products > CD45 & Myosin > Anti-CD45 x Anti-Myosin Bispecific Antibody (IgG-IgG)

Anti-CD45 x Anti-Myosin Bispecific Antibody (IgG-IgG)  (BSIG-122)

Anti-CD45 x Anti-Myosin Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-CD45 and anti-Myosin parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can recruit stem cells to infarcted myocardium. It is designed for the research of Myocardial infarction therapy.

Specifications

Targets
CD45 & Myosin
Type
IgG-IgG
Species Reactivity
Human
Target 1
CD45
Host Animal 1
Mouse
Target 2
Myosin
Host Animal 2
Mouse
Application
FuncS; Promising therapeutic agent
Related Disease
Myocardial infarction

Targets

Target 1
CD45
Gene ID
UniProt ID
Alternative Names
PTPRC; CD45; Cluster of differentiation 45; protein tyrosine phosphatase, receptor type C; LCA; LY5; B220; CD45; L-CA; T200; CD45R; GP180
Target 2
Myosin
Alternative Names
Myosin; ATP-dependent motor proteins

Customer Reviews and Q&As

There are currently no customer reviews or questions for Anti-CD45 x Anti-Myosin Bispecific Antibody (IgG-IgG) (BSIG-122). Click the button below to contact us or submit your feedback about this product.

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Welcome! For price inquiries, we will get back to you as soon as possible.

To order, please email

INQUIRY
Related products of "CD45 & Myosin"
Online Inquiry

24x7 Service quality
USA

Tel:
Fax:
Email:

UK

Tel:
Email:

Germany

Tel:
Email: